guest ::
| Home > Publications database > Super enhancers define regulatory subtypes and cell identity in neuroblastoma > print |
| Home > Publications database > Super enhancers define regulatory subtypes and cell identity in neuroblastoma > print |
| 001 | 166292 | ||
| 005 | 20240229133519.0 | ||
| 024 | 7 | _ | |a 10.1038/s43018-020-00145-w |2 doi |
| 024 | 7 | _ | |a altmetric:95588965 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-02785 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Gartlgruber, Moritz |0 P:(DE-He78)5190aa0a28a0d3d663954c463290e4c1 |b 0 |e First author |
| 245 | _ | _ | |a Super enhancers define regulatory subtypes and cell identity in neuroblastoma |
| 260 | _ | _ | |a London |c 2021 |b Nature Research |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1692698221_25035 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:B087#LA:B087# VOL 2 | JANUARy 2021 | 114–128 |
| 520 | _ | _ | |a Half of the children diagnosed with neuroblastoma (NB) have high-risk disease, disproportionately contributing to overall childhood cancer-related deaths. In addition to recurrent gene mutations, there is increasing evidence supporting the role of epigenetic deregulation in disease pathogenesis. Yet, comprehensive cis-regulatory network descriptions from NB are lacking. Here, using genome-wide H3K27ac profiles across 60 NBs, covering the different clinical and molecular subtypes, we identified four major super-enhancer-driven epigenetic subtypes and their underlying master regulatory networks. Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. The fourth subtype, exhibiting mesenchymal characteristics, shared cellular identity with multipotent Schwann cell precursors, was induced by RAS activation and was enriched in relapsed disease. Notably, CCND1, an essential gene in NB, was regulated by both mesenchymal and adrenergic regulatory networks converging on distinct super-enhancer modules. Overall, this study reveals subtype-specific super-enhancer regulation in NBs. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Sharma, Ashwini Kumar |0 P:(DE-He78)ef6b064b6d3463cee768ed2e261c10cd |b 1 |u dkfz |
| 700 | 1 | _ | |a Quintero, Andrés |0 0000-0002-3959-805X |b 2 |
| 700 | 1 | _ | |a Dreidax, Daniel |0 P:(DE-He78)00d281bd33b8c1254cbe4f048dbfaa14 |b 3 |
| 700 | 1 | _ | |a Jansky, Selina |0 P:(DE-He78)0d2f8ea0917f8fb1a5668af95b36bd8b |b 4 |
| 700 | 1 | _ | |a Park, Young-Gyu |0 P:(DE-He78)1dca75c95409803396496586047ae881 |b 5 |
| 700 | 1 | _ | |a Kreth, Sina |0 P:(DE-He78)21d657d65d4ad0fd8b0bbfe10fa65172 |b 6 |
| 700 | 1 | _ | |a Meder, Johanna |0 P:(DE-He78)196067e8183923fe7b74eb55f85cb503 |b 7 |
| 700 | 1 | _ | |a Doncevic, Daria |0 P:(DE-He78)dd50491ca9154efffd0f52480e15f592 |b 8 |
| 700 | 1 | _ | |a Saary, Paul |b 9 |
| 700 | 1 | _ | |a Toprak, Umut H. |0 P:(DE-He78)cd8295952c28dc5b483b5ba9386a5669 |b 10 |
| 700 | 1 | _ | |a Ishaque, Naveed |b 11 |
| 700 | 1 | _ | |a Afanasyeva, Elena |0 P:(DE-He78)00a05211e3c20e831f301cbacab8e5f2 |b 12 |
| 700 | 1 | _ | |a Wecht, Elisa |0 P:(DE-He78)8f7a0515aec950d7157b3932b942503f |b 13 |
| 700 | 1 | _ | |a Koster, Jan |0 0000-0002-0890-7585 |b 14 |
| 700 | 1 | _ | |a Versteeg, Rogier |0 0000-0001-7172-0388 |b 15 |
| 700 | 1 | _ | |a Grünewald, Thomas |0 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |b 16 |
| 700 | 1 | _ | |a Jones, David T. W. |0 P:(DE-He78)551bb92841f634070997aa168d818492 |b 17 |
| 700 | 1 | _ | |a Pfister, Stefan M. |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 18 |
| 700 | 1 | _ | |a Henrich, Kai-Oliver |0 P:(DE-He78)a579ca2567736066534409e732b31c91 |b 19 |
| 700 | 1 | _ | |a van Nes, Johan |0 0000-0001-7691-1431 |b 20 |
| 700 | 1 | _ | |a Herrmann, Carl |0 P:(DE-HGF)0 |b 21 |
| 700 | 1 | _ | |a Westermann, Frank |0 P:(DE-He78)91f32735ee876c579d63c05a7f4778dd |b 22 |e Last author |
| 773 | _ | _ | |a 10.1038/s43018-020-00145-w |0 PERI:(DE-600)3005299-3 |p 114–128 |t Nature cancer |v 2 |y 2021 |x 2662-1347 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:166292 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)5190aa0a28a0d3d663954c463290e4c1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)ef6b064b6d3463cee768ed2e261c10cd |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 0000-0002-3959-805X |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)00d281bd33b8c1254cbe4f048dbfaa14 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)0d2f8ea0917f8fb1a5668af95b36bd8b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)1dca75c95409803396496586047ae881 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)21d657d65d4ad0fd8b0bbfe10fa65172 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)dd50491ca9154efffd0f52480e15f592 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)cd8295952c28dc5b483b5ba9386a5669 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)00a05211e3c20e831f301cbacab8e5f2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)8f7a0515aec950d7157b3932b942503f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)551bb92841f634070997aa168d818492 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)a579ca2567736066534409e732b31c91 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)91f32735ee876c579d63c05a7f4778dd |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-09-04 |
| 915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2022-11-08 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT CANCER : 2021 |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-08 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-08 |
| 915 | _ | _ | |a IF >= 20 |0 StatID:(DE-HGF)9920 |2 StatID |b NAT CANCER : 2021 |d 2022-11-08 |
| 920 | 1 | _ | |0 I:(DE-He78)B087-20160331 |k B087 |l B087 Neuroblastom Genomik |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B410-20160331 |k B410 |l Translationale Pädiatrische Sarkomforschung |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)B360-20160331 |k B360 |l Pädiatische Gliomforschung |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 4 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B087-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B410-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B360-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|